Swiss National Bank’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.9M Buy
218,800
+14,600
+7% +$3.19M 0.03% 443
2025
Q1
$45.7M Sell
204,200
-700
-0.3% -$157K 0.03% 429
2024
Q4
$67.1M Sell
204,900
-11,600
-5% -$3.8M 0.04% 340
2024
Q3
$65M Sell
216,500
-200
-0.1% -$60K 0.04% 361
2024
Q2
$71.4M Sell
216,700
-4,900
-2% -$1.61M 0.05% 326
2024
Q1
$87.7M Sell
221,600
-9,400
-4% -$3.72M 0.06% 289
2023
Q4
$81.3M Sell
231,000
-7,800
-3% -$2.75M 0.06% 297
2023
Q3
$89.6M Sell
238,800
-29,400
-11% -$11M 0.07% 269
2023
Q2
$103M Sell
268,200
-25,600
-9% -$9.79M 0.07% 275
2023
Q1
$102M Sell
293,800
-7,100
-2% -$2.46M 0.07% 283
2022
Q4
$70.8M Sell
300,900
-20,075
-6% -$4.72M 0.05% 357
2022
Q3
$79M Sell
320,975
-1,200
-0.4% -$295K 0.06% 324
2022
Q2
$97.4M Buy
322,175
+1,300
+0.4% +$393K 0.07% 286
2022
Q1
$132M Buy
320,875
+39,700
+14% +$16.3M 0.07% 256
2021
Q4
$132M Sell
281,175
-10,700
-4% -$5.02M 0.08% 243
2021
Q3
$124M Sell
291,875
-10,600
-4% -$4.5M 0.08% 240
2021
Q2
$109M Sell
302,475
-12,525
-4% -$4.5M 0.07% 287
2021
Q1
$88.8M Buy
315,000
+36,100
+13% +$10.2M 0.06% 322
2020
Q4
$79M Sell
278,900
-7,600
-3% -$2.15M 0.06% 331
2020
Q3
$78.8M Sell
286,500
-5,700
-2% -$1.57M 0.06% 302
2020
Q2
$66.4M Buy
292,200
+5,200
+2% +$1.18M 0.06% 328
2020
Q1
$43.7M Buy
287,000
+54,300
+23% +$8.27M 0.05% 378
2019
Q4
$35M Buy
232,700
+94,400
+68% +$14.2M 0.04% 468
2019
Q3
$19.6M Buy
138,300
+300
+0.2% +$42.5K 0.02% 578
2019
Q2
$17.3M Buy
138,000
+3,000
+2% +$375K 0.02% 609
2019
Q1
$14.9M Buy
135,000
+5,000
+4% +$551K 0.02% 632
2018
Q4
$12.7M Buy
130,000
+1,000
+0.8% +$98K 0.02% 617
2018
Q3
$15.9M Hold
129,000
0.02% 619
2018
Q2
$12.8M Hold
129,000
0.01% 652
2018
Q1
$11.4M Buy
129,000
+3,000
+2% +$265K 0.01% 664
2017
Q4
$12.4M Buy
126,000
+3,000
+2% +$296K 0.01% 654
2017
Q3
$11.8M Buy
123,000
+1,000
+0.8% +$96.3K 0.01% 652
2017
Q2
$11.5M Buy
122,000
+1,100
+0.9% +$104K 0.01% 652
2017
Q1
$9.87M Buy
120,900
+500
+0.4% +$40.8K 0.01% 682
2016
Q4
$10.2M Buy
120,400
+2,200
+2% +$187K 0.02% 645
2016
Q3
$8.81M Sell
118,200
-2,400
-2% -$179K 0.01% 669
2016
Q2
$9.15M Buy
120,600
+1,200
+1% +$91.1K 0.01% 665
2016
Q1
$7.99M Buy
119,400
+25,500
+27% +$1.71M 0.01% 683
2015
Q4
$5.66M Hold
93,900
0.01% 739
2015
Q3
$5.08M Buy
93,900
+12,400
+15% +$671K 0.01% 771
2015
Q2
$4.73M Buy
81,500
+1,900
+2% +$110K 0.01% 796
2015
Q1
$4.79M Buy
79,600
+1,000
+1% +$60.2K 0.01% 802
2014
Q4
$4.19M Buy
78,600
+1,800
+2% +$95.8K 0.02% 800
2014
Q3
$3.44M Sell
76,800
-1,000
-1% -$44.8K 0.01% 892
2014
Q2
$3.28M Hold
77,800
0.01% 950
2014
Q1
$3.43M Buy
77,800
+17,300
+29% +$762K 0.01% 897
2013
Q4
$2.97M Sell
60,500
-8,500
-12% -$417K 0.01% 841
2013
Q3
$2.84M Buy
69,000
+6,200
+10% +$255K 0.01% 816
2013
Q2
$2.21M Buy
+62,800
New +$2.21M 0.01% 931